Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 200

1.

Melanins of Inonotus Obliquus: Bifidogenic and Antioxidant Properties.

Burmasova MA, Utebaeva AA, Sysoeva EV, Sysoeva MA.

Biomolecules. 2019 Jun 24;9(6). pii: E248. doi: 10.3390/biom9060248.

2.

The pharmacological potential and possible molecular mechanisms of action of Inonotus obliquus from preclinical studies.

Duru KC, Kovaleva EG, Danilova IG, van der Bijl P.

Phytother Res. 2019 Jun 17. doi: 10.1002/ptr.6384. [Epub ahead of print] Review.

PMID:
31209936
3.

Inotodiol inhibits cells migration and invasion and induces apoptosis via p53-dependent pathway in HeLa cells.

Zhang SD, Yu L, Wang P, Kou P, Li J, Wang LT, Wang W, Yao LP, Zhao XH, Fu YJ.

Phytomedicine. 2019 May 13:152957. doi: 10.1016/j.phymed.2019.152957. [Epub ahead of print]

PMID:
31128995
4.

Two forms of substrate for the bioluminescent reaction in three species of basidiomycetes.

Puzyr AP, Burov AE, Medvedeva SE, Burova OG, Bondar VS.

Mycology. 2019 Feb 23;10(2):84-91. doi: 10.1080/21501203.2019.1583688. eCollection 2019 Jun.

5.

Inonotus obliquus polysaccharides protect against Alzheimer's disease by regulating Nrf2 signaling and exerting antioxidative and antiapoptotic effects.

Han Y, Nan S, Fan J, Chen Q, Zhang Y.

Int J Biol Macromol. 2019 Jun 15;131:769-778. doi: 10.1016/j.ijbiomac.2019.03.033. Epub 2019 Mar 13.

PMID:
30878614
6.

Inonotus obliquus polysaccharide ameliorates dextran sulphate sodium induced colitis involving modulation of Th1/Th2 and Th17/Treg balance.

Chen YF, Zheng JJ, Qu C, Xiao Y, Li FF, Jin QX, Li HH, Meng FP, Jin GH, Jin D.

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):757-766. doi: 10.1080/21691401.2019.1577877.

PMID:
30856346
7.

Lanostane-type triterpenes from the sclerotium of Inonotus obliquus (Chaga mushrooms) as proproliferative agents on human follicle dermal papilla cells.

Sagayama K, Tanaka N, Fukumoto T, Kashiwada Y.

J Nat Med. 2019 Jun;73(3):597-601. doi: 10.1007/s11418-019-01280-0. Epub 2019 Jan 31.

PMID:
30706371
8.

Three-Phase Partitioning for the Extraction and Purification of Polysaccharides from the Immunomodulatory Medicinal Mushroom Inonotus obliquus.

Liu Z, Yu D, Li L, Liu X, Zhang H, Sun W, Lin CC, Chen J, Chen Z, Wang W, Jia W.

Molecules. 2019 Jan 22;24(3). pii: E403. doi: 10.3390/molecules24030403.

9.

Synergistic effects of surfactant-assisted biodegradation of wheat straw and production of polysaccharides by Inonotus obliquus under submerged fermentation.

Xu X, Wu P, Wang T, Yan L, Lin M, Chen C.

Bioresour Technol. 2019 Apr;278:43-50. doi: 10.1016/j.biortech.2019.01.022. Epub 2019 Jan 8.

PMID:
30677697
10.

Chemical Characterization and Hypoglycaemic Activities In Vitro of Two Polysaccharides from Inonotus obliquus by Submerged Culture.

Xue J, Tong S, Wang Z, Liu P.

Molecules. 2018 Dec 10;23(12). pii: E3261. doi: 10.3390/molecules23123261.

11.

The polysaccharide from Inonotus obliquus protects mice from Toxoplasma gondii-induced liver injury.

Xu L, Sang R, Yu Y, Li J, Ge B, Zhang X.

Int J Biol Macromol. 2019 Mar 15;125:1-8. doi: 10.1016/j.ijbiomac.2018.11.114. Epub 2018 Nov 13.

PMID:
30445083
12.

Actions of Inonotus obliquus against Hyperuricemia through XOD and Bioactives Screened by Molecular Modeling.

Yong T, Chen S, Liang D, Zuo D, Diao X, Deng C, Wu Y, Hu H, Xie Y, Chen D.

Int J Mol Sci. 2018 Oct 18;19(10). pii: E3222. doi: 10.3390/ijms19103222.

13.

Synthesis of porous Pd nanoparticles by therapeutic chaga extract for highly efficient tri-modal cancer treatment.

Gil YG, Kang S, Chae A, Kim YK, Min DH, Jang H.

Nanoscale. 2018 Nov 1;10(42):19810-19817. doi: 10.1039/c8nr07172a.

PMID:
30334053
14.

Immunopotentiating effect of Inonotus obliquus fermentation products administered at vaccination in chickens.

Zhang L, Lin D, Li H, Yu S, Bai J, Ding Z, Wu J.

Mol Cell Probes. 2018 Oct;41:43-51. doi: 10.1016/j.mcp.2018.09.002. Epub 2018 Sep 15.

PMID:
30227259
15.

Structure Characterization and Hypoglycaemic Activities of Two Polysaccharides from Inonotus obliquus.

Liu P, Xue J, Tong S, Dong W, Wu P.

Molecules. 2018 Aug 4;23(8). pii: E1948. doi: 10.3390/molecules23081948.

16.

Lanostane-Type Triterpenes and Abietane-Type Diterpene from the Sclerotia of Chaga Medicinal Mushroom, Inonotus obliquus (Agaricomycetes), and Their Biological Activities.

Alzand KI, Ünal S, Boufaris MSM.

Int J Med Mushrooms. 2018;20(6):507-516. doi: 10.1615/IntJMedMushrooms.2018026007.

PMID:
29953348
17.

Bioactivity-based analysis and chemical characterization of cytotoxic constituents from Chaga mushroom (Inonotus obliquus) that induce apoptosis in human lung adenocarcinoma cells.

Baek J, Roh HS, Baek KH, Lee S, Lee S, Song SS, Kim KH.

J Ethnopharmacol. 2018 Oct 5;224:63-75. doi: 10.1016/j.jep.2018.05.025. Epub 2018 May 22.

PMID:
29800742
18.

Effects of polysaccharides from Inonotus obliquus and its chromium (III) complex on advanced glycation end-products formation, α-amylase, α-glucosidase activity and H2O2-induced oxidative damage in hepatic L02 cells.

Wang C, Gao X, Santhanam RK, Chen Z, Chen Y, Xu L, Wang C, Ferri N, Chen H.

Food Chem Toxicol. 2018 Jun;116(Pt B):335-345. doi: 10.1016/j.fct.2018.04.047. Epub 2018 Apr 22.

PMID:
29689356
19.

Antiproliferative Activity and Cytotoxicity of Some Medicinal Wood-Destroying Mushrooms from Russia.

Shnyreva AV, Shnyreva AA, Espinoza C, Padrón JM, Trigos Á.

Int J Med Mushrooms. 2018;20(1):1-11. doi: 10.1615/IntJMedMushrooms.2018025250.

PMID:
29604909
20.

Chaga ( Inonotus obliquus), a Future Potential Medicinal Fungus in Oncology? A Chemical Study and a Comparison of the Cytotoxicity Against Human Lung Adenocarcinoma Cells (A549) and Human Bronchial Epithelial Cells (BEAS-2B).

Géry A, Dubreule C, André V, Rioult JP, Bouchart V, Heutte N, Eldin de Pécoulas P, Krivomaz T, Garon D.

Integr Cancer Ther. 2018 Sep;17(3):832-843. doi: 10.1177/1534735418757912. Epub 2018 Feb 27.

Supplemental Content

Loading ...
Support Center